Key facts
- This page summarizes Rick E. Winningham's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Feb 2025, 19:32.
Rick E. Winningham - 20 Feb 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- TBPH
- Reported as of
- 20 Feb 2025
- Net transaction value
- -$339,346
- SEC form
- 4
- Accepted by SEC
- 24 Feb 2025, 19:32:45 UTC
- Prior SEC filing
- 22 Nov 2024
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brett A. Grimaud, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Rick E. Winningham filed Form 4 for Theravance Biopharma, Inc. (TBPH) on 24 Feb 2025.
Change
- Previous filing in this sequence was filed on 22 Nov 2024.
- Current net transaction value: -$339,346.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TBPH
transaction
Ordinary Shares
Tax liability
- Transaction value
- $339,346
- Shares
- -35,129
- Change %
- -1.9%
- Price
- $9.66
- Shares after
- 1,775,966
- Date
- 20 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
TBPH
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,900
- Date
- 20 Feb 2025
- Ownership
- As Custodian
TBPH
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 92,567
- Date
- 20 Feb 2025
- Ownership
- By Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.